The relationship between Toll-like receptor 9 gene polymorphisms and the outcomes of hepatitis B virus infection
10.3760/cma.j.issn.1674-2397.2011.01.008
- VernacularTitle:Toll样受体9基因多态性与HBV感染结局的相关性研究
- Author:
Hongxia LI
;
Li CHEN
;
Lijun XU
;
Xinhua LI
;
Jiankai FANG
;
Qinguang LI
;
Ronghua CHEN
;
Chen PAN
- Publication Type:Journal Article
- Keywords:
Hepatitis B;
Toll-like receptor 9;
Polymorphism,single nucleotide
- From:
Chinese Journal of Clinical Infectious Diseases
2011;04(1):36-39
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate whether the clinical outcomes of HBV infection are associated with single nucleotide polymorphisms of Toll-like receptor (TLR) 9 gene promoter region.Methods The polymorphisms of three positions at TLR9 gene promoter region including A-1923C, T-1486C and T-1237C were detected using real-time fluorescence quantitative polymerase chain reaction in 96 patients with severe chronic hepatitis B, 156 patients with chronic hepatitis B and 151 cases of HBV spontaneous clearance, then the differences between the groups were analyzed.Analysis of variance was performed for measurement data,and χ2 test or Fisher exact probability test were used for enumeration data.Results The frequency of AC genotype at TLR9 gene A-1923C site in chronic hepatitis B group was 3.8%, which was significantly lower than that in HBV spontaneous clearance group (11.3%) (χ2=6.082, P ＜ 0.05), but no significant difference was found between severe chronic hepatitis B group (8.3%) and HBV spontaneous clearance group (χ2=0.552, P ＞0.05).No significant differences of genotype distribution were found between chronic severe hepatitis B group and HBV spontaneous clearance group , chronic hepatitis B group and HBV spontaneous clearance group at polymorphism sites of T-1486C and T-1237C (χ2=1.534 and 0.745, P ＞ 0.05).Conclusions Genotype AC at TLR9 gene A-1923C site is associated with HBV spontaneous clearance, but not correlated with chronic HBV infection and liver failure; there is no correlation of polymorphisms in T-1486C and T-1237C at TLR9 gene promoter region with the clinical outcomes of HBV infection.
